Literature DB >> 2706246

Tight-binding inhibition of angiogenin and ribonuclease A by placental ribonuclease inhibitor.

F S Lee1, R Shapiro, B L Vallee.   

Abstract

The dissociation rate constant of the angiogenin-placental ribonuclease inhibitor complex was determined by measuring the release of free angiogenin from the complex in the presence of scavenger for free placental ribonuclease inhibitor (PRI). In 0.1 M NaCl, pH 6, 25 degrees C, this value is 1.3 X 10(-7) s-1 (t1/2 congruent to 60 days). The Ki value for the binding of PRI to angiogenin, calculated from the association and dissociation rate constants, is 7.1 X 10(-16) M. The corresponding values for the interaction of RNase A with PRI, determined by similar means, are both considerably higher: the dissociation rate constant is 1.5 X 10(-5) s-1 (t1/2 = 13 h), and the Ki value is 4.4 X 10(-14) M. Thus, PRI binds about 60 times more tightly to angiogenin than to RNase A. The effect of increasing sodium chloride concentration on the binding of PRI to RNase A was explored by Henderson plots. The Ki value increases to 39 pM in 0.5 M NaCl and to 950 pM in 1 M NaCl, suggesting the importance of ionic interactions. The mode of inhibition of RNase A by PRI was determined by examining the effect of a competitive inhibitor of RNase A, cytidine 2'-phosphate, on the association rate of PRI with RNase A. Increasing concentrations of cytidine 2'-phosphate decrease the association rate in a manner consistent with a competitive mode of inhibition.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2706246     DOI: 10.1021/bi00427a031

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  52 in total

1.  Second generation antitumour human RNase: significance of its structural and functional features for the mechanism of antitumour action.

Authors:  S Di Gaetano; G D'alessio; R Piccoli
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

Review 2.  Cancer chemotherapy--ribonucleases to the rescue.

Authors:  P A Leland; R T Raines
Journal:  Chem Biol       Date:  2001-05

3.  Site-specific PEGylation endows a mammalian ribonuclease with antitumor activity.

Authors:  Thomas J Rutkoski; John A Kink; Laura E Strong; Ronald T Raines
Journal:  Cancer Biol Ther       Date:  2011-08-01       Impact factor: 4.742

4.  Specific binding of angiogenin to calf pulmonary artery endothelial cells.

Authors:  J Badet; F Soncin; J D Guitton; O Lamare; T Cartwright; D Barritault
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

5.  Tuning the pK(a) of fluorescein to optimize binding assays.

Authors:  Luke D Lavis; Thomas J Rutkoski; Ronald T Raines
Journal:  Anal Chem       Date:  2007-08-03       Impact factor: 6.986

Review 6.  Ribonuclease inhibitor: structure and function.

Authors:  Kimberly A Dickson; Marcia C Haigis; Ronald T Raines
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2005

7.  Structural features for the mechanism of antitumor action of a dimeric human pancreatic ribonuclease variant.

Authors:  Antonello Merlino; Giovanna Avella; Sonia Di Gaetano; Angela Arciello; Renata Piccoli; Lelio Mazzarella; Filomena Sica
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

8.  Selective abolition of pancreatic RNase binding to its inhibitor protein.

Authors:  Kapil Kumar; Michael Brady; Robert Shapiro
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-17       Impact factor: 11.205

9.  Ribonuclease A variants with potent cytotoxic activity.

Authors:  P A Leland; L W Schultz; B M Kim; R T Raines
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

10.  Intraspecies regulation of ribonucleolytic activity.

Authors:  R Jeremy Johnson; Luke D Lavis; Ronald T Raines
Journal:  Biochemistry       Date:  2007-10-23       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.